Rana Boussi
Clinical Operations Director

Clinical Research professional with more than 10 years of experience in Phase I to IV clinical studies in a wide range of therapeutic areas. Her experience includes 3 years of experience as a project manager within various organizations. She was also a CRA manager and mentor for 4 years, after having accumulated 3 years of monitoring experience herself.

She now holds the position of Clinical Operations Director, in charge of all internal and external operations in regards to the performance clinical trials.

Experience

Immunotherapy – Phase III & II in Hepato-carcinoma; Metastatic or unresectable melanoma; Non-small cell lung cancer; Cutaneous Squamous Cell carcinoma; Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma; Selected solid tumors; Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer; Severe sialorrhea
Chemotherapy – Phase IV & III & II in Non-Small-Cell Lung Cancer, Advanced or Metastatic Breast cancer; Renal cell carcinoma; Head and neck cancer; Haematology Non-Hodgkin's lymphoma; Chronic Myeloid Leukemia; Multiple myeloma
Small molecule – Phase IV & III & II/III & II in Haematology Cytomegalovirus; Bacterial Infections in pediatric populations; Pulmonary; Respiratory Metabolism & endocrinology Orthopedics Idiopathic Pulmonary Fibrosis; COPD; Narcolepsia
Vaccine – Phase III & II in HIV infection; Ebola Virus Disease
Medical device – Phase I in Neurology Catatonia Phase II in Acute Hepatic Porphyria; synthetic RNA interference (observational natural history); Tyrosinemia / Inhibitors (Phase I/II) Scoliosis and spine surgery, Medical devices (Phase III and post-market) Orthopedics / Medical devices (post-market)
Antibody drug conjugate – Phase I in Advanced solid tumor